Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Lipocine (LPCN) over the last 9 years, with Q3 2025 value amounting to $174208.0.

  • Lipocine's Non Operating Income fell 5768.11% to $174208.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $835060.0, marking a year-over-year decrease of 3260.29%. This contributed to the annual value of $1.2 million for FY2024, which is 2630.76% down from last year.
  • Per Lipocine's latest filing, its Non Operating Income stood at $174208.0 for Q3 2025, which was down 5768.11% from $198637.0 recorded in Q2 2025.
  • Lipocine's 5-year Non Operating Income high stood at $895754.0 for Q2 2022, and its period low was -$3.8 million during Q2 2021.
  • For the 5-year period, Lipocine's Non Operating Income averaged around $48619.4, with its median value being $291292.0 (2024).
  • Examining YoY changes over the last 5 years, Lipocine's Non Operating Income showed a top increase of 63202.37% in 2021 and a maximum decrease of 15507.13% in 2021.
  • Over the past 5 years, Lipocine's Non Operating Income (Quarter) stood at -$159926.0 in 2021, then soared by 307.22% to $331401.0 in 2022, then dropped by 5.96% to $311653.0 in 2023, then fell by 24.05% to $236704.0 in 2024, then decreased by 26.4% to $174208.0 in 2025.
  • Its last three reported values are $174208.0 in Q3 2025, $198637.0 for Q2 2025, and $225511.0 during Q1 2025.